Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2050907

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2050907

Bovine Mastitis Market, by Type, by Product, by Route of Administration, by Therapy, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Bovine Mastitis Market is estimated to be valued at USD 1,652.2 Mn in 2026 and is expected to reach USD 2,419.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,652.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.60% 2033 Value Projection: USD 2,419.4 Mn

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.

Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.

Market Dynamics

One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2021, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global bovine mastitis market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies.
  • Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global bovine mastitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine mastitis market

Detailed Segmentation:

  • Global Bovine Mastitis Market, By Type (Revenue, USD Mn, 2021 - 2033)
  • Clinical Mastitis
  • Sub-clinical Mastitis
  • Global Bovine Mastitis Market, By Product (Revenue, USD Mn, 2021 - 2033)
  • Antibiotics
  • Vaccines
  • Pain Killers
  • Others
  • Global Bovine Mastitis Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
  • Intra-mammary
  • Systemic
  • Global Bovine Mastitis Market, By Therapy (Revenue, USD Mn, 2021 - 2033)
  • Lactating Period
  • Dry Period
    • Antibiotics
    • Teat Sealants
  • Global Bovine Mastitis Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Veterinary Centers
  • Hospital
  • Clinics
  • Others
  • Global Bovine Mastitis Market, By Region (Revenue, USD Mn, 2021 - 2033)
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • Zoetis
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd
Product Code: CMI4947

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Product
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Therapy
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Opportunity Map

3. Global Bovine Mastitis Market Insights

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Market Trends
  • Key Developments
  • Technological Advancement
  • Product Launch/Approvals
  • Acquisition, Collaboration & Agreements
  • Regulatory Scenario
  • Epidemiology
  • PEST Analysis

4. Global Bovine Mastitis Market, By Type, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Clinical Mastitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Sub-clinical Mastitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

5. Global Bovine Mastitis Market, By Product, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Pain Killers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

6. Global Bovine Mastitis Market, By Route of Administration, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Intra-mammary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Systemic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Bovine Mastitis Market, By Therapy, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Lactating Period
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Dry Period
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
      • Antibiotics
      • Teat Sealants

8. Global Bovine Mastitis Market, By End User, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Veterinary Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

9. Global Bovine Mastitis Market, By Region, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Region at Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021-2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021-2033, (US$ Million)
      • South Africa
      • Central Africa
      • North Africa

10. Competitive Snapshot

  • Company Profiles
    • Zoetis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elanco
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ceva
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • West Way Health
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Norbrook
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • DeLaval
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ImmuCell Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Advanced Animal Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nimrod Veterinary Products Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

11. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!